ABSTRACT
INTRODUCTION
The feasibility of fetoscopic laser coagulation of placental vascular anastomoses in twin-twin transfusion syndrome (TTTS) was first shown by De Lia et al. 1 in 1990 after laparotomy and under general anesthesia. In contrast to serial amnioreduction, this treatment addresses directly the underlying cause of TTTS. Subsequently, Ville et al. 2 introduced the direct transcutaneous fetoscopic approach under local anesthesia. The superiority of laser coagulation therapy over serial amnioreduction regarding survival rates has subsequently been demonstrated in a population-based trial and a randomized controlled trial (RCT) 3, 4 . Furthermore, laser therapy of TTTS leads to an improvement in long-term neurodevelopmental outcome [5] [6] [7] [8] . However, laser therapy may lead to complications such as iatrogenic preterm prelabor rupture of membranes 9 , twin anemia-polycythemia sequence (TAPS) 10 , reversal or recurrence of TTTS 11 and intrauterine fetal death.
Since laser coagulation for TTTS was introduced in the early 1990s, almost 4000 TTTS procedures have been reported worldwide 12 . However, most reports from single centers have included fewer than 200 cases. While overall there is a significant trend of improvement in perinatal survival rates over the last 25 years, the reported outcomes show a large variation between individual centers. We hypothesized that the outcome of laser therapy for TTTS depends on the experience and caseload of a center and that there is a continuous learning curve for centers performing this procedure, including further developments in the technique of fetoscopic laser surgery.
METHODS
We report the perinatal outcome of 1020 consecutive pregnant women with severe mid-trimester TTTS who were referred to our center for endoscopic laser coagulation of placental vascular anastomoses between January 1995 and March 2013. Outcome data for the first 400 patients of this population have been reported previously by our group 13, 14 . For these studies, ethical committee approval had been obtained but was no longer necessary when laser therapy became the standard medical treatment for TTTS. All patients gave written informed consent for the procedure and consented to their clinical data being used for research purposes. All fetal and procedural data were entered prospectively into a fetal database (ViewPoint Bildverarbeitung GmbH, Wessling, Germany) as were follow-up data as soon as they were available from the referral centers, which were located all over Germany, in other European countries and in the Middle East, and where further care of pregnancy was managed and delivery took place. For blockwise comparison of data, the whole population was divided into five sequential groups, of 200 patients for the first four and 220 for the last one.
The diagnosis of TTTS was made according to established criteria 15 , with polyhydramnios of the recipient fetus and anhydramnios of the stuck donor fetus, and staging was according to that of Quintero et al. 16 . Chorionicity was established by first-trimester sonographic examination at the referring center and confirmed during detailed sonographic examination at our center. The parents were counseled extensively regarding expectant management, endoscopic laser ablation of the communicating vessels, amniodrainage and termination of pregnancy.
All procedures were performed under local anesthesia as previously reported 13, 14, 17 . Briefly, the fetoscope (0 The primary outcome was survival of two fetuses and secondary outcome variables were survival of at least one fetus, gestational age at delivery, interval between laser treatment and delivery in pregnancies with at least one liveborn neonate, birth weight and neonatal morbidity. Survival was defined as survival of the neonatal period at discharge from hospital. Severe prematurity was defined as delivery before 32 completed weeks' gestation, and neonatal morbidity as intracerebral hemorrhage (Grades 3 and 4), periventricular leukomalacia, sepsis, bronchopulmonary dysplasia, necrotizing enterocolitis or any other severely debilitating disease, or need for blood transfusion.
Continuous variables are reported as mean ± SD and categorical variables as n (%). Depending on scale type of the dependent variable, linear or logistic regression analysis was performed for baseline variables as well as for outcomes, adjusted for type of fetoscope, gestational age at laser treatment, Quintero stage and surgeon. Model-based marginal means with corresponding 95% CIs were tested using F-tests, linear contrast tests or corresponding likelihood ratio tests, as appropriate. The learning curve of the surgeons was estimated by the application of locally weighted scatterplot smoothing (Lowess) with a bandwidth of 0.8 19 . Nominal P-values are reported without correction for multiplicity, and two-sided P < 0.05 was considered to indicate statistical significance. Statistical analysis was conducted using STATA (Version 14.0, StataCorp, College Station, TX, USA).
RESULTS
Baseline characteristics and outcomes for the total population and the five subgroups are given in Tables 1  and 2 . The yearly caseload more than doubled during the Data are shown as mean ± SD, n or n (%). *Global F-test for group comparison. †Linear contrast test for linear trend. GA, gestational age. Table 2 Perinatal outcome of sequential groups of fetuses with twin-twin transfusion syndrome treated by fetoscopic laser coagulation 5 and Graef et al. 6 . BW, birth weight; GA, gestational age; LB, live birth; NA, not applicable; TOP, termination of pregnancy. study period, from 43 cases in the first group to 91 in the last group. Gestational age at laser therapy did not show a significant difference between the subgroups, the mean gestational age for all 1020 cases being 20.8 ± 2.2 weeks. Significant differences between the treatment groups were observed for Quintero stages. More cases with Quintero stage I were treated in the later than in the earlier groups and there was a significant reduction in the time needed for fetoscopy (Table 1) .
Group 1 Group 2 Group 3 Group 4 Group 5 Total
To avoid potential confounders for perinatal outcome, adjustment for Quintero stage, fetoscope, gestational age at laser treatment and surgeon was performed in the subsequent outcome analysis. Perinatal outcomes were obtained for all cases except one (in Group 4). Table 2 and Figure 1 show the percentages of double-twin survival for intergroup comparison of the five chronological treatment subgroups and for the total study group. The percentage was 50.0% (100/200) in the first and increased to 69.5% (153/220) in the last group, reaching a plateau after the third group. After adjusting for confounders, the linear trend was significant (linear P = 0.018). There was a significant increase in survival of recipients, from 71.5% to 85.5% (P = 0.022) and a significant decrease in intrauterine deaths of recipients (P = 0.007). Survival of donors increased non-significantly, from 59.0% to 75.9% (P = 0.083). Table 2 and Figure 2 show the percentages of at least one survivor for intergroup comparison and for the total study population. There was a non-significant trend, with an increase from 80.5% (161/200) to 91.8% (202/220) (P = 0.072).
In the first two groups, 124 twin pairs had anterior placenta and were treated using 0
• fetoscopes. These cases showed a double-twin survival rate of 44.4% (55/124). After the 30
• fetoscope became available, it was used for anterior placentae. This led to a significant increase in double-twin survival, to 65.1% (207/318) (over all groups P = 0.001). Figure 3 shows double-twin survival rates before and after introduction of the 30
• fetoscope. There was no longer a significant difference in survival rate between anterior and posterior placental location. For all pregnancies with at least one liveborn neonate, the mean gestational age at delivery was 33.7 ± 3.2 weeks, with a time interval between laser treatment and delivery of 12.9 ± 4.0 weeks, and an incidence of severe prematurity with delivery at or before 32 weeks of 29.0% (262/905). The mean birth weight of recipients was 2056 ± 601 g and for donors it was 1769 ± 580 g, without any significant difference between groups. Furthermore, there was no significant difference in rates of severe neonatal morbidity between Groups 3, 4 and 5. Overall, severe neonatal morbidity occurred in 7% of both surviving recipients and donors for which neonatal follow-up reports were available. Recurrent TTTS or TAPS was reported in 2.7% (17/619) of the patients in these groups. Data on composite morbidity were not consistently available for Groups 1 and 2. Figure 4 shows the success rate of double-twin survival for the lead surgeon, which reached a plateau in the third group. In addition, the learning curve of another operator, who was trained hands-on and performed 174 procedures in the last two groups, is shown. There was no difference between the success rates of the experienced surgeon and the trainee, which was 70% overall. This was also the case for the operator who performed only 33 procedures.
DISCUSSION
To our knowledge, this is the largest single-center study of perinatal outcome after laser therapy for severe TTTS, with practically 100% (1019/1020) follow-up. We report our experience of almost 20 years, including the learning curve, new technical developments and training. The caseload per year doubled over the study period, during which there was a significant improvement in double-twin survival rates. Furthermore, after the introduction of a special fetoscope for cases with anterior placenta, differences in survival rate according to placental location were eliminated and, with an experienced surgeon supervising hands-on training, trainees achieved the same double-twin survival rate from soon after starting to perform the procedure.
Most outcome data on laser coagulation for TTTS published between 1995 and 2014 were derived from smaller studies, with the vast majority of these studies reporting on fewer than 200 cases. Double-twin survival rates increased significantly, from 31% to 62%, reflecting learning-curve effects, heterogeneity of the study populations and evolution of the technique 12 . Survival rates for at least one twin increased significantly, from 70% to 88%. The largest population, including 682 cases with laser surgery performed between 2002 and 2010 at two centers, reported a survival rate of 67% for both twins, which differed significantly according to stage, and 91% for at least one twin 20 .
In a meta-analysis of studies published between 1995 and 2009 focusing on survival of at least one twin, Ahmed et al. 21 found no significant impact of experience and improvements in technique (represented by date of publication), caseload or stage distribution. However, they did not analyze the influence of these parameters on double-twin survival, which is the primary aim of intrauterine therapy for TTTS, as there are two severely affected fetuses. In contrast, Morris et al. 22 reported a significant improvement in perinatal survival of at least one twin with increasing operator experience in a single-center setting with 164 consecutive cases treated by laser coagulation. However, they did not evaluate the effects of operator experience on double-twin survival either.
In our population we found a significant increase in double-twin survival rate, from 50% to 70% in the first and last groups, respectively, and a non-significant increase in the rate of survival of at least one fetus, from 81% to 92%. A plateau was reached after 600 cases had been treated. The increase in double-twin survival rate in the first three groups reflects the growing experience and learning curve of the lead operator, the development of a selective technique, the introduction of the 30
• fetoscope for anterior placentae in the second group and training of a new operator in the third group. The new fetoscope for anterior placentae led to a significant improvement in double-twin survival rates in these cases, which was comparable with that of cases with posterior or lateral placentae.
The differences in stage distribution between groups, with an increase in Stage I cases in Groups 4 and 5, may have contributed to the increase in double-twin survival rates. However, this is unlikely, as the plateau had already been reached after the first three groups and P-values were adjusted for Quintero stage. Furthermore, the largest study analyzing stage-dependent survival rates showed no significant differences in double-twin survival between Stages I and II, but differences were primarily due to decreased donor-twin survival in Stage-III cases 20 . A recent paper from the North American Fetal Therapy Network reported that the majority (60%) of expectantly managed Stage-I cases progressed, and only laser therapy was protective against poor outcome, which was defined as double fetal demise or delivery before 26.0 weeks' gestation 23 . The increase in Stage-I cases in our population may be a consequence of either earlier referral or increased awareness of minimal bladder filling in the donor twin.
Of two studies using the cumulative summation (CUSUM) test to determine the learning curve of individual surgeons, one analyzed the success rate for at least one survivor 24 and the other for double-twin survival 25 . In the first study, of 171 consecutive cases, an observer-trained operator needed 60 procedures, whereas hands-on trained operators needed only 20 procedures to reach an acceptable success rate. In the second study, of 340 consecutive cases, four operators reached an acceptable level of competence after 25-35 procedures. In our study, the learning curve for double-twin survival of the fourth operator, who performed 39.5% (174/440) of procedures in Groups 4 and 5, showed the same success rate as for the lead operator. This may be explained by his starting with the first procedures in technically easier cases with posterior placentae, the possibility of immediate intervention by the supervising experienced operator if technical difficulties occurred and a final check as to whether all anastomoses had been coagulated. It is possible that in the future a recently developed procedure-specific evaluation tool to assess the performance of trainees may be helpful in ensuring that they have reached a sufficient level of competence to perform the procedure unsupervised 26 . Our study supports the view that laser coagulation for TTTS and other intrauterine surgical interventions should be concentrated, nationwide as well as internationally, in specialized high-volume centers in which all procedures are registered prospectively. Two recent studies, one from Norway and one from Finland, have shown substantial improvement in survival and immediate and longer-term outcomes after congenital-heart-defect surgery and among pediatric cardiac surgery patients 27, 28 . In addition to advances in diagnostics and surgical methods as well as postoperative intensive care, in both countries operations have been fully centralized to, and performed only by highly experienced teams at, the Oslo University Hospital since 2003 and the Helsinki University Hospital since 1997. For outcome assessment, both centers obtained status and mortality data from their respective national population registry.
The introduction of minimum volume standards for hospitals performing specific complex surgical interventions and transplantation in Germany seems not to have been completely effective 29 . In contrast, as our significant increase in caseload over the study period shows, for laser coagulation in pregnancies with TTTS, centralization seems to have been driven mainly by referring fetal medicine specialists and patient demand. However, we do not have any nationwide data for comparison, as there is no national population registry in Germany, and intrauterine surgery is not listed in German hospital quality reports. Our study also shows that, for small countries, international centralization may be an alternative, which avoids patients having to go through a local learning curve (smaller national centers that started performing laser therapy have described similar learning curves to ours [30] [31] [32] ). This is emphasized by our referral pattern from several European countries, the majority from Norway, but also from countries which are further away, for example in the Middle East. A small case series has shown that even long-distance air travel is safe for women before and after laser treatment 33 .
A limitation of this study is the fact that follow-up data of surviving neonates are not complete. This is due to several reasons, the most important being the lack of a systematic registration of long-term follow-up for the whole population over a time period of more than 20 years. Furthermore, studies on specific complications after laser therapy, such as TAPS 34, 35 , have only recently been published and, therefore, standardized reports on these complications were not requested from referral centers. As a consequence, the incidence of long-term morbidity may be underreported. However, we have published several studies on long-term morbidity of subpopulations of the first two blocks of patients, focusing on neurodevelopmental follow-up and on the cardiovascular system 5, 6, [36] [37] [38] [39] . In two consecutive series investigating neurodevelopmental outcome at a median age of 2 and 3 years, respectively, 11% and 7% showed minor and 11% and 6% major neurological abnormalities, and at a median age of 6 years the results were not significantly different (overall 11% and 9%, respectively) 5, 6, 36 . This is in accordance with a study by van Klink et al. 40 , who reported a decrease in neurodevelopmental impairment from 18% to 6% with a concomitant increase in fetal survival in two consecutive cohorts of TTTS treated with laser surgery, which was explained by different factors, mainly improvements in prenatal care strategies, learning-curve effects and the development of new techniques. Follow-up studies investigating cardiovascular development in survivors of our first group have shown that cardiac dysfunction regressed after laser therapy and vascular programming resembled that seen in dichorionic twins 37 . However, there was an increased incidence of pulmonary stenosis (8%), affecting both former recipients and donors, at 10 years of age 38 .
Another limitation of our study is that, apart from the introduction of the 30
• fetoscope for anterior placentae, we were not able to investigate the influence of different techniques, such as the selective sequential and the Solomon techniques 12 . The former has not been applied systematically by our group, apart from to placentae with large arteriovenous anastomoses in the direction of recipient to donor, in which case we aimed at coagulating them at the end of the laser procedure. The results of a multicenter RCT comparing laser coagulation of the entire vascular equator with selective coagulation of anastomoses was published after our study period in 2014 by Slaghekke et al. 41 . They found a significantly lower incidence of TAPS or recurrent TTTS in the Solomon group as compared with the standard group (4% vs 21%), whereas no difference was found in mortality and severe neonatal morbidity as well as survival without neurodevelopmental impairment at 2 years of age (67% vs 68%) 41, 42 . However, the trial was not powered to detect differences in long-term outcome, and not all centers participated in the follow-up study. Therefore, an appropriately powered RCT with long-term neurodevelopmental follow-up has been suggested 43 . The concern that follow-up data on complications, such as TAPS and recurrent TTTS, may be underestimated in our study has already been expressed. However, we did apply the Solomon technique, to a certain extent, long before it was formally introduced in a study protocol by coagulating an area of neighboring anastomoses along a line on the vascular equator of the placenta. Furthermore, we always aimed to inspect the whole vascular equator from margin to margin to avoid missing thin anastomoses.
In conclusion, more than 20 years of experience with laser therapy in TTTS shows a significant increase in double-twin survival rate. Several factors, such as the learning-curve effect, technical developments and improvements in ultrasound monitoring and early referrals of monochorionic pregnancies with signs of TTTS, may have contributed to this success. Our data provide strong arguments for the centralization of minimally invasive intrauterine surgery, such as laser therapy, in specialized high-volume centers with an experienced team that also supervises hands-on training, thus allowing trainees to achieve the same double-twin survival rate as an experienced operator from the start of their use of the technique.
